Chapter 14: Genitourinary Secondary Conditions

Chapter 14

Genitourinary Secondary Conditions


Introduction to Genitourinary Secondary Connections

Genitourinary conditions frequently develop as secondary effects of service-connected disabilities. The genitourinary system’s complex interplay with vascular, neurological, and endocrine systems makes it particularly vulnerable to cascading effects from various primary conditions, whether through direct physiological impact, medication side effects, or neurological mechanisms.

Key Concepts

Genitourinary secondary conditions typically develop through these pathways:

  • Medication effects on kidney function, urinary tract, or reproductive organs
  • Vascular changes affecting genitourinary perfusion
  • Neurological effects on bladder, sphincter, or sexual function
  • Endocrine disruption affecting reproductive function
  • Mechanical effects from musculoskeletal conditions

This chapter explores the most common genitourinary conditions that develop secondary to service-connected disabilities and provides the medical evidence and documentation strategies needed to successfully claim these conditions.

Kidney Conditions Secondary to Diabetes, Hypertension, or Medication Effects

Kidney conditions—including chronic kidney disease, diabetic nephropathy, and medication-induced nephropathy—frequently develop as secondary conditions to service-connected diabetes, hypertension, and medication side effects.

Medical Connection

The development of kidney conditions as secondary effects occurs through several established mechanisms:

Secondary to Diabetes Mellitus

Diabetes affects kidney function through:

  • Glomerular hyperfiltration: Early increased filtration damages kidneys
  • Glycosylation of proteins: Damages kidney structures
  • Microvascular damage: Affects small vessels in kidneys
  • Increased susceptibility to infection: Leading to pyelonephritis
  • Papillary necrosis: Death of renal papillae
  • Increased risk of kidney stones: From metabolic changes

Secondary to Hypertension

Hypertension affects kidney function through:

  • Increased intraglomerular pressure: Damages filtering units
  • Arteriosclerosis of renal vessels: Narrows blood supply
  • Glomerulosclerosis: Scarring of glomeruli
  • Tubular ischemia: Reduced blood flow to tubules
  • Proteinuria: Protein leakage damages tubules
  • Activation of inflammatory pathways: Promotes fibrosis

Secondary to Medication Effects

Various medications can affect kidney function:

  • NSAIDs: Reduce renal blood flow, cause interstitial nephritis
  • Certain antibiotics: Direct tubular toxicity
  • Contrast agents: Cause contrast-induced nephropathy
  • Proton pump inhibitors: Associated with interstitial nephritis
  • Lithium: Causes nephrogenic diabetes insipidus, chronic tubulointerstitial nephropathy
  • Chemotherapy agents: Many have nephrotoxic effects

Case Study: Diabetic Nephropathy Secondary to Diabetes

A veteran with service-connected diabetes mellitus (40% rating) developed progressive kidney dysfunction. His successful secondary claim included:

  • Nephrology evaluation diagnosing diabetic nephropathy
  • Laboratory evidence:
    • Elevated creatinine (1.8 mg/dL)
    • Reduced eGFR (42 mL/min/1.73m²)
    • Persistent microalbuminuria
  • Renal ultrasound showing changes consistent with diabetic nephropathy
  • Nephrologist’s opinion stating that “the veteran’s chronic kidney disease is directly caused by his service-connected diabetes mellitus, as evidenced by the classic presentation, absence of other risk factors, and well-established causal relationship between diabetes and nephropathy”
  • Documentation of progression from normal kidney function to Stage 3b CKD over 8 years of diabetes
  • Evidence of required medication adjustments due to reduced kidney function

The VA granted service connection for diabetic nephropathy as secondary to diabetes mellitus with a 60% rating based on renal dysfunction with constant albuminuria and decreased kidney function.

Common Patterns of Secondary Kidney Conditions

Primary Condition Kidney Condition Characteristics
Diabetes mellitus Diabetic nephropathy Progressive albuminuria, gradual GFR decline, often with retinopathy
Hypertension Hypertensive nephrosclerosis Gradual GFR decline, minimal proteinuria, vascular changes
Chronic pain requiring NSAIDs NSAID nephropathy Acute or chronic interstitial nephritis, papillary necrosis
Bipolar disorder requiring lithium Lithium nephropathy Nephrogenic diabetes insipidus, chronic tubulointerstitial disease
Cancer requiring chemotherapy Chemotherapy-induced nephrotoxicity Varies by agent, may be acute or chronic, tubular or glomerular

Documentation Strategies

To establish kidney conditions as secondary, focus on documenting:

  • Nephrology evaluation and diagnosis
  • Laboratory evidence:
    • Serum creatinine and BUN
    • Estimated glomerular filtration rate (eGFR)
    • Urinalysis showing proteinuria, hematuria, or casts
    • Urine albumin-to-creatinine ratio
    • 24-hour urine collections if performed
  • Imaging studies:
    • Renal ultrasound
    • CT scan if performed
    • Nuclear medicine studies if performed
  • Kidney biopsy results if performed
  • Baseline kidney function prior to primary condition
  • For diabetes-related kidney disease:
    • Duration and control of diabetes
    • Hemoglobin A1c levels
    • Presence of other diabetic complications
  • For hypertension-related kidney disease:
    • Blood pressure records
    • Duration and severity of hypertension
    • Evidence of other end-organ damage
  • For medication-induced kidney disease:
    • Complete medication history
    • Dosages and duration
    • Temporal relationship to kidney dysfunction
    • Challenge/dechallenge information if available
  • Treatment requirements:
    • Medication adjustments
    • Dietary restrictions
    • Dialysis if required
  • Functional impact:
    • Fatigue and reduced stamina
    • Work limitations
    • Activity restrictions
  • Specialist opinions addressing the causal relationship
  • Research literature supporting the specific connection

Rating Consideration

Kidney conditions are typically rated under Diagnostic Code 7502 (chronic nephritis) or other codes based on renal dysfunction, with ratings from 0% to 100% based on laboratory values, symptoms, and treatment requirements. Document all laboratory evidence of kidney dysfunction, particularly creatinine, GFR, and albumin/protein in urine, as well as any required treatments like dialysis, to support proper rating.

Urinary Tract Conditions Secondary to Neurological Disorders or Medication Effects

Urinary tract conditions—including neurogenic bladder, urinary incontinence, and urinary retention—frequently develop as secondary conditions to service-connected neurological disorders, spinal conditions, and medication side effects.

Medical Connection

The development of urinary tract conditions as secondary effects occurs through several mechanisms:

Secondary to Neurological Disorders

Neurological conditions affect urinary function through:

  • Disruption of central control: Brain injuries affecting micturition centers
  • Spinal cord injury: Interrupting neural pathways to bladder
  • Peripheral neuropathy: Affecting sensory and motor nerves to bladder
  • Autonomic dysregulation: Affecting bladder tone and sphincter coordination
  • Multiple sclerosis plaques: Affecting spinal or brain control centers

Secondary to Medication Effects

Various medications can affect urinary function:

  • Anticholinergics: Cause urinary retention
  • Alpha-blockers: Can cause urinary incontinence
  • Diuretics: Increase urinary frequency and urgency
  • Sedatives: Reduce awareness of bladder filling
  • Antidepressants: Many affect urinary function
  • Calcium channel blockers: Can cause urinary retention

Case Study: Neurogenic Bladder Secondary to Lumbar Spine Condition

A veteran with service-connected lumbar degenerative disc disease with radiculopathy (40% rating) developed urinary retention and overflow incontinence. His successful secondary claim included:

  • Urology evaluation diagnosing neurogenic bladder
  • Urodynamic testing showing detrusor areflexia and high post-void residual
  • MRI showing severe lumbar stenosis with cauda equina compression
  • EMG studies confirming S2-S4 nerve root involvement
  • Urologist’s opinion stating that “the veteran’s neurogenic bladder is directly caused by his service-connected lumbar spine condition, as evidenced by the pattern of urodynamic findings consistent with cauda equina syndrome and the anatomical correlation with imaging studies”
  • Documentation of required intermittent catheterization four times daily
  • Evidence of recurrent urinary tract infections from catheterization

The VA granted service connection for neurogenic bladder as secondary to lumbar spine condition with a 60% rating based on urinary retention requiring intermittent catheterization and recurrent infections.

Common Patterns of Secondary Urinary Tract Conditions

Primary Condition Urinary Condition Characteristics
Spinal cord injury or disease Neurogenic bladder May be spastic (upper motor neuron) or flaccid (lower motor neuron)
Traumatic brain injury Urge incontinence Sudden, strong urge to urinate with leakage
Diabetic neuropathy Overflow incontinence Bladder doesn’t empty completely, leakage with full bladder
Multiple sclerosis Mixed urinary symptoms Combination of retention, urgency, and incontinence
Parkinson’s disease Urge incontinence Frequency, urgency, nocturia, often with constipation

Documentation Strategies

To establish urinary tract conditions as secondary, focus on documenting:

  • Urology evaluation and diagnosis
  • Objective testing:
    • Urodynamic studies
    • Post-void residual measurements
    • Cystoscopy if performed
    • Imaging of urinary tract
  • Detailed symptom description:
    • Type of incontinence (stress, urge, overflow, mixed)
    • Frequency of urination
    • Nocturia (nighttime urination)
    • Hesitancy, weak stream, straining
    • Sensation of incomplete emptying
  • For neurological-related urinary conditions:
    • Neurological evaluation records
    • Imaging studies showing relevant pathology
    • Temporal relationship to neurological symptoms
  • For medication-induced urinary conditions:
    • Complete medication history
    • Temporal relationship to symptom onset
    • Response to medication changes
  • Treatment requirements:
    • Catheterization (frequency and type)
    • Medications
    • Surgical interventions
    • Absorbent materials (type and frequency of change)
  • Complications:
    • Urinary tract infections
    • Skin breakdown
    • Kidney damage from reflux
  • Functional impact:
    • Work limitations
    • Social restrictions
    • Sleep disruption
    • Need for proximity to restrooms
  • Specialist opinions addressing the causal relationship
  • Research literature supporting the specific connection

Rating Consideration

Urinary tract conditions are rated under various diagnostic codes (7512-7517) based on voiding dysfunction, urinary frequency, or obstructed voiding. Ratings range from 0% to 60% based on specific symptoms and treatment requirements. Document all aspects of urinary dysfunction, particularly the need for catheterization, use of absorbent materials and frequency of changing, and any urinary frequency or obstructive symptoms to support proper rating.

Erectile Dysfunction Secondary to Diabetes, Vascular Conditions, or Medication Effects

Erectile dysfunction (ED)—the inability to achieve or maintain an erection sufficient for sexual performance—frequently develops as a secondary condition to service-connected diabetes, vascular conditions, neurological disorders, and medication side effects.

Medical Connection

The development of erectile dysfunction as a secondary condition occurs through several mechanisms:

Secondary to Diabetes Mellitus

Diabetes affects erectile function through:

  • Endothelial dysfunction: Impairs nitric oxide-mediated vasodilation
  • Microvascular disease: Affects small vessels in penile tissue
  • Peripheral neuropathy: Affects nerves controlling erection
  • Autonomic neuropathy: Disrupts neural control of erection
  • Hormonal imbalances: Reduced testosterone levels

Secondary to Vascular Conditions

Vascular disorders affect erectile function through:

  • Atherosclerosis: Reduces blood flow to penile arteries
  • Hypertension: Damages endothelial function
  • Venous leak: Inability to maintain blood in erectile tissue
  • Endothelial dysfunction: Impairs vasodilation
  • Shared risk factors: ED often precedes other vascular events

Secondary to Medication Effects

Various medications can cause erectile dysfunction:

  • Antihypertensives: Especially beta-blockers and thiazide diuretics
  • Antidepressants: Particularly SSRIs and SNRIs
  • Antipsychotics: Through multiple mechanisms
  • Antiandrogens: Used for prostate conditions
  • Opioids: Affect hormonal balance
  • H2 blockers: Some affect hormonal balance

Case Study: Erectile Dysfunction Secondary to Diabetes

A veteran with service-connected diabetes mellitus (40% rating) developed complete erectile dysfunction unresponsive to oral medications. His successful secondary claim included:

  • Urology evaluation diagnosing organic erectile dysfunction
  • Penile Doppler ultrasound showing reduced arterial flow
  • Hormone testing showing normal testosterone levels
  • Documentation of diabetic peripheral neuropathy
  • Failed trials of PDE5 inhibitors (sildenafil, tadalafil)
  • Urologist’s opinion stating that “the veteran’s erectile dysfunction is at least as likely as not caused by his service-connected diabetes mellitus, as evidenced by the concurrent development of peripheral neuropathy, vascular insufficiency on Doppler studies, and the absence of other risk factors”
  • Evidence of psychological impact on marriage and self-esteem

The VA granted service connection for erectile dysfunction as secondary to diabetes mellitus with special monthly compensation for loss of use of a creative organ.

Common Patterns of Secondary Erectile Dysfunction

Primary Condition Mechanism for ED Characteristics
Diabetes mellitus Vascular and neurological Gradual onset, often with other complications, poor response to oral medications
Hypertension Vascular and medication effects May improve with medication changes, vascular pattern on testing
PTSD/depression treated with SSRIs Medication effects Temporal relationship to medication, may improve with dose adjustment
Spinal cord injury Neurogenic Level of injury determines pattern, may have reflex erections without sensation
Prostate cancer treatment Surgical, radiation, or hormonal Immediate onset after surgery, gradual after radiation, hormonal effects

Documentation Strategies

To establish erectile dysfunction as a secondary condition, focus on documenting:

  • Urology evaluation and diagnosis
  • Objective testing if performed:
    • Penile Doppler ultrasound
    • Nocturnal penile tumescence testing
    • Hormone levels (testosterone, prolactin)
    • Neurological testing
  • Detailed symptom description:
    • Complete vs. partial ED
    • Gradual vs. sudden onset
    • Presence of morning erections
    • Ability to achieve vs. maintain erection
  • For diabetes-related ED:
    • Duration and control of diabetes
    • Presence of other diabetic complications
    • Temporal relationship to diabetes diagnosis
  • For vascular-related ED:
    • Vascular studies
    • Cardiovascular risk factors
    • Other evidence of vascular disease
  • For medication-induced ED:
    • Complete medication history
    • Temporal relationship to ED onset
    • Response to medication changes
  • Treatment history:
    • Oral medications tried and results
    • Injections or other treatments
    • Consideration of implants
  • Psychological impact:
    • Effects on relationships
    • Mental health consequences
    • Quality of life impact
  • Specialist opinions addressing the causal relationship
  • Research literature supporting the specific connection

Rating Consideration

Erectile dysfunction itself is typically rated at 0% under Diagnostic Code 7522 unless there is deformity of the penis with loss of erectile power, which warrants a 20% rating. However, erectile dysfunction usually qualifies for special monthly compensation (SMC) for loss of use of a creative organ. Document the complete inability to achieve an erection sufficient for sexual intercourse and failed treatments to support the SMC claim.

Female Reproductive Conditions Secondary to Endocrine Disorders or Medication Effects

Female reproductive conditions—including menstrual disorders, premature ovarian insufficiency, and fertility issues—can develop as secondary conditions to service-connected endocrine disorders and medication side effects.

Medical Connection

The development of female reproductive conditions as secondary effects occurs through several mechanisms:

Secondary to Endocrine Disorders

Endocrine conditions affect female reproductive function through:

  • Hypothalamic-pituitary-gonadal axis disruption: Alters hormone signaling
  • Thyroid dysfunction: Affects menstrual cycle and fertility
  • Adrenal disorders: Alter sex hormone production
  • Diabetes: Affects ovarian function and increases pregnancy complications
  • Hyperprolactinemia: Suppresses ovulation

Secondary to Medication Effects

Various medications can affect female reproductive function:

  • Chemotherapy: Can cause premature ovarian insufficiency
  • Certain antipsychotics: Raise prolactin, disrupt menstruation
  • Antiepileptic drugs: Some affect hormone metabolism
  • Corticosteroids: Disrupt hypothalamic-pituitary function
  • Opioids: Suppress hypothalamic-pituitary-gonadal axis
  • Certain antidepressants: May affect sexual function and menstruation

Case Study: Premature Ovarian Insufficiency Secondary to Chemotherapy

A 32-year-old female veteran with service-connected Hodgkin’s lymphoma (in remission, 30% rating) underwent chemotherapy with alkylating agents. Six months after treatment, she developed amenorrhea, hot flashes, and was diagnosed with premature ovarian insufficiency. Her successful secondary claim included:

  • Gynecology evaluation diagnosing premature ovarian insufficiency
  • Laboratory evidence:
    • Elevated FSH and LH levels
    • Low estradiol levels
    • Normal prolactin and thyroid function
  • Oncology records documenting chemotherapy regimen known to cause ovarian damage
  • Documentation of regular menstrual cycles prior to chemotherapy
  • Reproductive endocrinologist’s opinion stating that “the veteran’s premature ovarian insufficiency is directly caused by chemotherapy for her service-connected Hodgkin’s lymphoma, as evidenced by the temporal relationship, her young age, the known gonadotoxic effects of her specific chemotherapy agents, and the absence of other risk factors”
  • Evidence of infertility and need for hormone replacement therapy
  • Documentation of psychological impact and quality of life effects

The VA granted service connection for premature ovarian insufficiency as secondary to treatment for service-connected Hodgkin’s lymphoma with a 30% rating based on symptoms requiring continuous treatment.

Common Patterns of Secondary Female Reproductive Conditions

Primary Condition Reproductive Condition Characteristics
Cancer requiring chemotherapy Premature ovarian insufficiency Amenorrhea, elevated gonadotropins, menopausal symptoms, infertility
Hypothyroidism Menstrual irregularities Heavy or irregular periods, anovulation, infertility
Hyperprolactinemia from medications Galactorrhea, amenorrhea Nipple discharge, absent periods, infertility
Diabetes mellitus Menstrual irregularities Irregular cycles, PCOS-like features, fertility issues
Chronic opioid therapy Hypogonadotropic hypogonadism Low estrogen, amenorrhea, decreased libido

Documentation Strategies

To establish female reproductive conditions as secondary, focus on documenting:

  • Gynecology or reproductive endocrinology evaluation
  • Laboratory evidence:
    • Hormone levels (FSH, LH, estradiol, progesterone)
    • Prolactin levels
    • Thyroid function tests
    • Other relevant hormones
  • Imaging studies if performed:
    • Pelvic ultrasound
    • Hysterosalpingogram
    • MRI if performed
  • Detailed menstrual history:
    • Pattern before primary condition
    • Changes after primary condition or treatment
    • Current pattern
  • For endocrine-related reproductive conditions:
    • Endocrinology evaluation records
    • Temporal relationship to endocrine diagnosis
    • Pattern of hormonal abnormalities
  • For medication-induced reproductive conditions:
    • Complete medication history
    • Dosages and duration
    • Temporal relationship to reproductive changes
    • Known effects of specific medications
  • Treatment requirements:
    • Hormone replacement therapy
    • Other medications
    • Fertility treatments if pursued
  • Symptoms and impact:
    • Menopausal symptoms if present
    • Pain or other physical symptoms
    • Fertility effects
    • Psychological impact
    • Relationship effects
  • Specialist opinions addressing the causal relationship
  • Research literature supporting the specific connection

Rating Consideration

Female reproductive conditions are rated under various diagnostic codes (7610-7629) based on specific conditions and symptoms. Many conditions are rated based on whether symptoms require continuous treatment. Document all symptoms, treatment requirements, and functional impacts thoroughly to support proper rating. For conditions causing infertility, special monthly compensation for loss of use of a creative organ may be applicable.

Evidence Checklist & Documentation Strategies

Genitourinary Secondary Conditions Evidence Checklist

  • Medical diagnosis of the secondary genitourinary condition
  • Treatment records for the primary service-connected condition
  • Specialist evaluations (urology, nephrology, gynecology)
  • Laboratory evidence (kidney function, hormone levels)
  • Imaging studies of relevant structures
  • Specialized testing results (urodynamics, Doppler studies)
  • Medication history showing drugs prescribed for service-connected conditions
  • Baseline genitourinary function prior to primary condition
  • Medical opinion linking the genitourinary condition to the primary condition
  • Timeline showing primary condition preceded genitourinary symptoms
  • Treatment requirements for the genitourinary condition
  • Documentation of complications (infections, fertility effects)
  • Functional impact assessment
  • Psychological impact statement if applicable
  • Personal statement describing how the primary condition led to genitourinary symptoms
  • Relevant medical literature supporting the genitourinary connection

Effective Documentation Approaches

For genitourinary secondary conditions, these documentation strategies are particularly effective:

Specialist Involvement

Genitourinary conditions require specialist evaluation:

  • Nephrologist for kidney conditions
  • Urologist for urinary tract and male reproductive conditions
  • Gynecologist for female reproductive conditions
  • Reproductive endocrinologist for complex hormonal issues
  • Neurourologist for neurogenic bladder

Objective Testing

Objective test results provide compelling evidence:

  • For kidney conditions: Creatinine, eGFR, urinalysis, imaging
  • For urinary conditions: Urodynamics, post-void residual, cystoscopy
  • For erectile dysfunction: Doppler studies, hormone levels
  • For female conditions: Hormone panels, ultrasound, specialized testing

Functional Impact Documentation

Document how genitourinary conditions affect function:

  • For kidney disease: Fatigue, dietary restrictions, dialysis needs
  • For urinary conditions: Frequency, pad usage, catheterization needs
  • For erectile dysfunction: Relationship effects, psychological impact
  • For female conditions: Pain, fertility effects, hormone replacement needs

Temporal Relationship

Document the timeline clearly:

  • Baseline genitourinary function before primary condition
  • Onset of primary condition or start of medication
  • First appearance of genitourinary symptoms
  • Progression of genitourinary condition
  • Response to treatment of primary condition

Expert Tip

For genitourinary conditions, particularly those related to medications, obtaining baseline testing results from before the medication was started can be extremely valuable evidence. If available, include pre-treatment laboratory values, imaging studies, or urodynamic testing showing normal function, followed by the post-treatment testing showing the changes. This clear “before and after” evidence strongly supports the causal relationship between the medication and the genitourinary condition.

© 2025 Ronald A. Bolton. All rights reserved.